Easton Pharmaceuticals is a specialty pharmaceutical company involved in various industries including medical marijuana who also owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues related towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company's gel formulation is thought to be an innovative and unique transdermal delivery system.
RIGHT NOW EASTON PHARMACEUTICLES IS IN THE PROCESS OF RAISING UP TO 5 MILLION DOLLARS IN FINANCING WITH ALREADY 1M RAISED IN THE LAST 9 MONTHS
CHECK OUT THE NEW RELEASE OF EASTON'S PRODUCT LINE OF HEMP BASED FORMUATIONS AND SEVERAL OTC PRODCUTS THAT WILL BE AVAILABLE FOR CONSUMER DISTRIBUTION
"Transdermal Solutions Clinically Researched and Proven Effective"
SKIN RENOU HA
MEET OUR EXPERTS
Daniel Bagi, M.D.
Senior Executive Physician Consultant
Daniel Bagi, M.D., is a senior executive physician with 20+ year’s international experience in the pharmaceutical industry, with expertise in product development as it pertains to clinical development for commercial use; medical affairs and clinical research, specifically oncology and gynecologic topical women’s health products.
Mr. Neil Mellor
Senior Consultant, Chief Operations Officer
Mr. Mellor has over 25 years of experience in the pharmaceutical industry, both in Canada and Europe. The majority of Mr. Mellor’s background is in sales, marketing and business development for companies such as Merck, Pharmacia (now Pfizer), and Solvay Pharma (now Abbott Laboratories). Over the past 10 years, Mr. Mellor has been Associate Director of Business Development at Solvay Pharma.
AS OF JUNE 2013 EAPH IS GOING GREEN IN MORE WAYS THAN ONE - Estimated $$9 Billion Industry within 5 years
The Venue for Medicinal Marijuana Should Lie With a
EAPH has all the right ingredients..!!
Add that to the Current $Multi-Billion Market EAPH is already
involved in with female topical pharmaceuticals!!
Easton Pharmaceuticals Announces the Completion and Shipping of the mPact -GROzone Antimicrobial System
Click each video to watch AMFIL’s lead scientist and inventor provided an introductory viewing and presentation of a finished mPact -GROzone unit prior
to being integrated into a commercially licensed, state of the art medical marijuana grow facility in Colorado.
The mPact -GROzone Antimicrobial Systems is an exclusive application geared initially towards the Medical Marijuana Industry and marijuana growing/processing facilities as well as other pharmaceutical and food related applications.
EAPH Security Details
|Market Value ||$20,866,216 ||a/o Apr 04, 2014 |
|Shares Outstanding ||498,000,370 ||a/o Apr 01, 2014 |
|Float ||473,245,458 ||a/o Apr 01, 2014 |
|Authorized Shares ||500,000,000 ||a/o Apr 01, 2014 |
|Par Value ||0.0001 |